Fidelis Pharmaceuticals Limited, a wholly indigenous Nigerian company, was founded in 2003 and commenced production in 2006 as a drug manufacturing outfit after approval and due recognition of relevant agencies and bodies including the National Agency for Food and Drug Administration and Control (NAFDAC) and the Pharmacists Council of Nigeria.(PCN).
From an initial product dosage form of dermatological antibiotic and anti fungal preparations, our facility now houses additional dosage form manufacturing areas for antibiotic dry syrups, capsules, tablets, ointments, creams, gels, powders, eye/ear drops, small and large volume liquid injectable preparations, nasal drops amongst others. In all modesty, we pride ourselves as the highest product portfolio carrier in the industry.
We are recruiting to fill the position below:
Job Title: Graduate Trainee
Job Location: Lagos
Job Descriptions
As part of our collective drive for professionalism and expansion of our stake in the various industries where we are major player, we are therefore soliciting for applications from qualified and smart fresh graduates with minimum of Second Class Lower or Lower credit from any reputable higher institution of learning.
The training will take place in Lagos, Nigeria is geared towards preparing the Graduate Trainee for other responsibilities in the organisation.
Requirements
- A minimum of OND/HND/B.Sc in a relevant field.
- Should not be more than 32 years old by June 30th, 2015
Skills Required
- Must be computer literate.
- Must possess a keen investigative mind and be able to learn very fast.
- Good team player with strong analytical mind.
- Ability to work under pressure and tight schedule, highly self motivated.
- Being able to recognize discrepancies.
- Having strong work ethic.
- Being able to articulate concepts and ideas both contextually and visually.
- Having good technical skills.
Due Date:5th June, 2015.
How To Apply
Interested and qualified applicants should forward their resumes to:fidelispharmaceuticals@qualityservice.com
No comments:
Post a Comment